MAPT and Alzheimer disease: Several recent in silico modeling studies suggest four binding sites on AD tau and highlighted the heterogeneity among probes binding to different tau strains: For the first-generation tracers, MK6240 and flortaucipir bind only to major binding site 1, while THK5351 binds to site 1 and 3, and PBB3 detects all four binding sites.